0000899243-18-031138.txt : 20181214 0000899243-18-031138.hdr.sgml : 20181214 20181214210052 ACCESSION NUMBER: 0000899243-18-031138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181212 FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: North Michael Paul CENTRAL INDEX KEY: 0001689925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 181236850 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-12 0 0000896262 AMEDISYS INC AMED 0001689925 North Michael Paul 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Information Officer Common Stock 2018-12-12 4 M 0 3750 32.56 A 25253 D Common Stock 2018-12-12 4 M 0 1875 32.56 A 27128 D Common Stock 2018-12-12 4 M 0 1895 46.35 A 29023 D Common Stock 2018-12-12 4 S 0 7520 134.79 D 21503 D Common Stock 391 I Through 401(k) Plan Stock Option (right to buy) 32.56 2018-12-12 4 M 0 3750 0.00 D 2025-06-02 Common Stock 3750 1875 D Stock Option (right to buy) 32.56 2018-12-12 4 M 0 1875 0.00 D 2025-06-02 Common Stock 1875 3750 D Stock Option (right to buy) 46.35 2018-12-12 4 M 0 1895 0.00 D 2027-01-20 Common Stock 1895 5682 D The total amount of shares beneficially owned includes 761 shares held in an employee stock purchase plan account. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $135.11, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The information in this report is based on a plan statement dated as of September 30, 2018. On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2016 were met, resulting in vesting of the option as to 5,625 shares (the "2016 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2016 Tranche Options vested on June 2, 2017, one-third of the 2016 Tranche Options vested on June 2, 2018 and the remaining one-third of the 2016 Tranche Options will vest on June 2, 2019, assuming the reporting person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the options. On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 5,625 shares (the "2017 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2017 Tranche Options vested on June 2, 2018, one-third of the 2017 Tranche Options will vest on June 2, 2019 and the remaining one-third of the 2017 Tranche Options will vest on June 2, 2020, assuming the reporting person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the options. On January 20, 2017, the reporting person was granted an option to purchase 7,577 shares of common stock. The options are subject to time-based vesting conditions. 1,895 of the options vested on January 20, 2018, and the remaining 5,682 options vest ratably on each of January 20, 2019, January 20, 2020 and January 20, 2021, provided that the reporting person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2018-12-14